These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28823305)

  • 21. Implementing liquid biopsies into clinical decision making for cancer immunotherapy.
    Quandt D; Dieter Zucht H; Amann A; Wulf-Goldenberg A; Borrebaeck C; Cannarile M; Lambrechts D; Oberacher H; Garrett J; Nayak T; Kazinski M; Massie C; Schwarzenbach H; Maio M; Prins R; Wendik B; Hockett R; Enderle D; Noerholm M; Hendriks H; Zwierzina H; Seliger B
    Oncotarget; 2017 Jul; 8(29):48507-48520. PubMed ID: 28501851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating cell-free DNA and circulating tumor cells, the "liquid biopsies" in ovarian cancer.
    Cheng X; Zhang L; Chen Y; Qing C
    J Ovarian Res; 2017 Nov; 10(1):75. PubMed ID: 29132396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
    Zhang W; Xia W; Lv Z; Ni C; Xin Y; Yang L
    Cell Physiol Biochem; 2017; 41(2):755-768. PubMed ID: 28214887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New horizon for breast cancer biomarker discoveries: What might the liquid biopsy of nipple aspirate fluid hold?
    Mannello F
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.
    Camus V; Jardin F; Tilly H
    Expert Rev Mol Diagn; 2017 Jun; 17(6):557-566. PubMed ID: 28415895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
    Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of circulating tumor cells in gastric cancer patients.
    Zhou J; Ma X; Bi F; Liu M
    Oncotarget; 2017 Apr; 8(15):25713-25720. PubMed ID: 28147337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent clinical research on the application of liquid biopsy in neuroblastoma.
    Liu SY; Wen FQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):339-344. PubMed ID: 35351268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis.
    Tadimety A; Syed A; Nie Y; Long CR; Kready KM; Zhang JX
    Integr Biol (Camb); 2017 Jan; 9(1):22-49. PubMed ID: 27929582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential use of urine cell free DNA as a marker for cancer.
    Salvi S; Martignano F; Molinari C; Gurioli G; Calistri D; De Giorgi U; Conteduca V; Casadio V
    Expert Rev Mol Diagn; 2016 Dec; 16(12):1283-1290. PubMed ID: 27796148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
    Nakamura K
    Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case-control Study Supporting the Use of Liquid Biopsy in the Targeted Therapy for Lung Cancer.
    Dai LJ; Wang C; Ding ZY
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1761-1766. PubMed ID: 30049184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients.
    Doval DC; Deshpande R; Dhabhar B; Babu KG; Prabhash K; Chopra R; Sripada PV; Deshmukh C; Suryavanshi M
    Indian J Cancer; 2017 Dec; 54(Supplement):S25-S30. PubMed ID: 29292705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer.
    von Bubnoff N
    Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.
    Esposito A; Criscitiello C; Locatelli M; Milano M; Curigliano G
    Pharmacol Ther; 2016 Jan; 157():120-4. PubMed ID: 26615782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicles compartment in liquid biopsies: Clinical application.
    Garcia-Romero N; Esteban-Rubio S; Rackov G; Carrión-Navarro J; Belda-Iniesta C; Ayuso-Sacido A
    Mol Aspects Med; 2018 Apr; 60():27-37. PubMed ID: 29155161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid Biopsy - The Non-invasive Tool for Tracking Cancer.
    Baig S; Jafarey O
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):417-418. PubMed ID: 29848413
    [No Abstract]   [Full Text] [Related]  

  • 40. [Breakthrough Technologies: Liquid Biopsy -Chairmen's Introductory Remarks.].
    Nakatani K; Furuta K
    Rinsho Byori; 2016 May; 64(4):392-393. PubMed ID: 29182804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.